Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression
Schwartz, H.S.; Grindey, G.B.
Cancer Research 33(8): 1837-1844
1973
ISSN/ISBN: 0008-5472 PMID: 4720795 Document Number: 61909
Document emailed within 1 workday
Related Documents
Wheeler, D.M. 1975: Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127) Cancer ChemoTherapy Reports 59(2 Part 1): 258-259van Bree, C.; Krooshoop, J.J.; Rietbroek, R.C.; Kipp, J.B.; Bakker, P.J. 1996: Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor Cancer Research 56(3): 563-568
Johnson, B.A.; Cheang, M.S.; Goldenberg, G.J. 1986: Comparison of adriamycin uptake in chick embryo heart and liver cells an murine L5178Y lymphoblasts in vitro: role of drug uptake in cardiotoxicity Cancer Research 46(1): 218-223
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53
Wang, T.; Zhang, J.-c.; Chen, Y.; Huang, F.; Yang, M.-s.; Xiao, P.-g. 2007: Comparison of antioxidative and antitumor activities of six flavonoids from Epimedium koreanum Zhongguo Zhong Yao Za Zhi 32(8): 715-718
Takahashi, N.; Brouckaert, P.; Fiers, W. 1991: Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice Cancer Research 51(9): 2366-2372
Goldenberg, G.J.; Wang, H.; Blair, G.W. 1986: Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 46(6): 2978-2983
Bartholeyns, J.; Koch-Weser, J. 1981: Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats Cancer Research 41(12 Pt 1): 5158-5161
Pan, X.Q.; Lee, R.J. 2005: In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model Anticancer Research 25(1a): 343-346
Chan, W.S.; Marshall, J.F.; Lam, G.Y.; Hart, I.R. 1988: Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors Cancer Research 48(11): 3040-3044
Dehaye, J.P.; Winand, J.; Christophe, J. 1977: Effect of lipolytic agents on calcium uptake in the epididymal adipose tissue of obese-hyperglycemic mice and their lean controls Archives Internationales de Physiologie et de Biochimie 85(2): 396-398
Warren, P.; Song, W.; Holle, E.; Holmes, L.; Wei, Y.; Li, J.; Wagner, T.; Yu, X. 2002: Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice Anticancer Research 22(2a): 599-604
Siveski-Iliskovic, N.; Hill, M.; Chow, D.A.; Singal, P.K. 1995: Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect Circulation 91(1): 10-15
Bozeman, E.N.; Srivatsan, S.; Mohammadi, H.; Daniels, D.; Shashidharamurthy, R.; Selvaraj, P. 2012: Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice Experimental Oncology 34(4): 340-347
Gautam, S.; Chikkala, N.; Ganapathi, R. 1992: Immunomodulation by adriamycin - effect on the production of cytotoxic and inflammatory antitumor immune-responses International Journal of Oncology 1(7): 799-805
Israel, M.; Modest, E.J.; Frei, E. 1975: N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin Cancer Research 35(5): 1365-1368
Eastland, G.W.; Yang, G.; Thompson, T. 1983: Studies of rhenium carboxylates as antitumor agents. Part II. Antitumor studies of bis (mu-propionato) diaquotetrabromodirhenium (III) in tumor-bearing mice Methods and Findings in Experimental and Clinical Pharmacology 5(7): 435-438
Bachur, N.R.; Reiter, W.; Arena, E. 1975: Cardiac uptake of adriamycin (NSC-124127) not affected by strophanthin G (NSC-25485) Cancer ChemoTherapy Reports 59(4): 765
Krishan, A.; Israel, M.; Modest, E.J.; Frei, E. 1976: Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate Cancer Research 36(6): 2108-2109
Kusumoto, H.; Maehara, Y.; Anai, H.; Kumashiro, R.; Sugimachi, K. 1991: Dipyridamole potentiates adriamycin cytotoxicity by a mechanism other than inhibiting nucleoside uptake Anticancer Research 11(4): 1539-1542